Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
Clinical trial NCT06180889 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06180889
- Sponsor
- Suzhou Alphamab Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-20
- Primary completion
- 2025-12-15
- Enrollment
- 241
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.